2014
DOI: 10.1161/cir.0000000000000031
|View full text |Cite|
|
Sign up to set email alerts
|

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

10
832
2
54

Year Published

2014
2014
2019
2019

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 2,026 publications
(898 citation statements)
references
References 928 publications
10
832
2
54
Order By: Relevance
“…According to the current guideline, the optimal timing of tricuspid surgery is determined: (1) by symptoms or progressive right ventricular dysfunction caused by severe primary TR; or (2) at the time of left‐side heart valve surgery 3, 4. The present study demonstrated that patients with a high MELD‐XI score (≥12.0) and MELD‐Albumin score (≥10.7) were at increased risk of an adverse event.…”
Section: Discussionmentioning
confidence: 65%
See 1 more Smart Citation
“…According to the current guideline, the optimal timing of tricuspid surgery is determined: (1) by symptoms or progressive right ventricular dysfunction caused by severe primary TR; or (2) at the time of left‐side heart valve surgery 3, 4. The present study demonstrated that patients with a high MELD‐XI score (≥12.0) and MELD‐Albumin score (≥10.7) were at increased risk of an adverse event.…”
Section: Discussionmentioning
confidence: 65%
“…Tricuspid annuloplasty (TA) is currently recommended for the treatment of significant TR3, 4 and has been increasingly performed over the past decade 5. Although TA has shown a satisfactory outcome in the short term, postoperative residual significant TR and mortality remain high during long‐term follow‐up 6, 7.…”
Section: Introductionmentioning
confidence: 99%
“…To quantify degree of AS in patients, peak velocity during systole was quantified at the aortic root using an oblique sagittal maximum intensity projection of the absolute velocity 22. Degree of AS was classified according to current guidelines with respect to the peak transvalvular vena contracta velocity, that is, no AS: <2.0 m/s; mild AS: 2.0 to 2.9 m/s; moderate AS: 3.0 to 3.9 m/s; and severe AS: ≥4.0 m/s 23. To simplify data interpretation, 3 AS groups were created, defined as patients having no AS, those with mild AS, and those with moderate and severe AS.…”
Section: Methodsmentioning
confidence: 99%
“…AV disease was assessed at visit 5 and was based primarily on the peak AV velocity, concordant with the 2014 American Heart Association/American College of Cardiology valvular heart disease guidelines 21. AV disease was classified as follows: (1) normal: peak AV velocity, <1.5 m/s; (2) sclerosis: peak AV velocity, ≥1.5 to <2.0 m/s; (3) mild stenosis: peak AV velocity, ≥2.0 to <3.0 m/s; (4) moderate or severe stenosis: peak AV velocity ≥3 m/s.…”
Section: Methodsmentioning
confidence: 99%